Home NDC 51407-032-10 Clopidogrel
Product NDC 51407-032
Requested package NDC 51407-032-10
11-digit product format 514070032
Labeler code 51407
Product ID 51407-032_d6e77117-3ec9-0bd5-e053-2a95a90aa4dc
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name clopidogrel bisulfate
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Golden State Medical Supply, Inc.
Application ANDA076274
Marketing category ANDA
Marketing start 2012-05-17
Marketing end 0000-00-00
Substance CLOPIDOGREL BISULFATE
Active strength 75 mg/1
Pharmacologic classes Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076274-001 CLOPIDOGREL BISULFATE CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 A076274-002 CLOPIDOGREL BISULFATE CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 c2088c7a36db…2026-09-14 22:38:34 2026-08 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 84e616aacf4f…2026-08-18 06:07:40 2026-07 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A076274-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-05-17 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A076274-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RS 2014-03-04 4b0b4de00fa7…
Observed Orange Book normalized TE history# Normalized TE history page 3 of 3 · 88 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 51407-032-10 Clopidogrel 1000 in 1 BOTTLE TABLET, FILM COATED 1000 10 51407-032-30 Clopidogrel 30 in 1 BOTTLE TABLET, FILM COATED 30 10 51407-032-90 Clopidogrel 90 in 1 BOTTLE TABLET, FILM COATED 90 10
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 51407-032 CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [GOLDEN STATE MEDICAL SUPPLY, INC.] 9 Legacy NDC, 3 package rows 20241213_84bb2c2c-4c41-4aa4-a52b-3d6eed794ada.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Clopidogrel CLOPIDOGREL BISULFATE Cardinal Health 107, LLC c03a895c-2d74-4d7f-891f-b752ce409b68 2026-04-21 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 076274 application number: ANDA076274 Clopidogrel CLOPIDOGREL BISULFATE Major Pharmaceuticals 4cd07a3c-9673-4aa0-b76a-d79df2399ee1 2025-09-08 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 076274 application number: ANDA076274 Clopidogrel CLOPIDOGREL BISULFATE Aphena Pharma Solutions - Tennessee, LLC d49362ae-f78a-47d8-ac14-8262d621fcaa 2021-03-18 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 076274 application number: ANDA076274
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 51407-032-10 51407003210 1000 TABLET, FILM COATED in 1 BOTTLE (51407-032-10) 2018-01-01 0000-00-00 No No Current